Division of General Internal Medicine and Public Health

December 5, 2013

Day of events highlights efforts to fight diabetes

Vanderbilt University’s contributions to the field of diabetes — past and present — were celebrated recently during the annual Diabetes Day at the Vanderbilt Student Life Center.

By Bill Snyder
February 21, 2013

VU experts help craft AMA paper on safe transitions for patients

“There and Home Again, Safely: 5 Responsibilities of Ambulatory Practices in High Quality Care Transitions,” a new white paper from the American Medical Association (AMA), is the work of a 19-member expert panel that included two Vanderbilt faculty members — Sunil Kripalani, M.D., M.Sc., associate professor of Medicine, and Amanda Salanitro M.D., MS, MSPH, instructor in Medicine, both from the section of Hospital Medicine in the Department of Medicine’s Division of General Internal Medicine and Public Health.

By Paul Govern
January 10, 2013

Study reviews medication adherence interventions

According to a medical literature review published last month in the Annals of Internal Medicine, approximately 50 percent of medications for chronic disease are not taken as prescribed.

By Paul Govern
November 8, 2012

Commonly prescribed oral diabetes drug offers cardiac benefits

Patients prescribed the diabetes drug metformin have a lower risk for heart attack, stroke and death than patients taking sulfonylurea drugs.

By VUMC News and Communications
Image of pain pills (iStock Photo)
July 19, 2012

Study tracks medication-related problems after hospital discharge

As more and better treatments are developed for heart disease, it is becoming more difficult to safely manage care as patients return home from the hospital. A new study led by Vanderbilt researchers highlights growing concern that the period after hospital discharge is a risky time, especially for cardiac patients.

By VUMC News and Communications
Clinical and translational research at Vanderbilt will be funded over the next five years, thanks to a $46 million renewal grant from the National Center for Advancing Translational Sciences. (Mary Donaldson/Vanderbilt)
July 12, 2012

Vanderbilt’s CTSA lands $46 million renewal

Vanderbilt University’s largest single government research grant, its Clinical and Translational Science Award (CTSA), has been renewed for another five years for $46 million.

By Bill Snyder
October 21, 2011

Initiative to help ‘translate’ diabetes research advances

The new Center for Diabetes Translation Research will translate scientific breakthroughs into practices that can be applied in the doctor’s office and the patient’s home.
By Bill Snyder
October 18, 2011

Predicting hospital readmission is risky business: study

Each year millions of Americans return to the hospital within 30 days of their previous discharge. Although many readmissions could be preventable, most statistical models for predicting them "perform poorly," according to researchers at Vanderbilt and the Oregon Health and Science University and their affiliated VA medical centers.
By Bill Snyder
1 … 4 5 6 7